IP Verse

Methods And Systems For Processing A Cell Culture - EP3047013

The patent EP3047013 was granted to Genzyme on Aug 18, 2021. The application was originally filed on Sep 16, 2014 under application number EP14780959A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3047013

GENZYME
Application Number
EP14780959A
Filing Date
Sep 16, 2014
Status
Granted And Under Opposition
Jul 16, 2021
Grant Date
Aug 18, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KONIG SZYNKA TILMANN VON RENESSEMay 18, 2022KONIG SZYNKA TILMANN VON RENESSE DUSSELDORFADMISSIBLE
KONIG SZYNKA TILMANN VON RENESSEMay 18, 2022KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (4) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUS2011111486
INTERNATIONAL-SEARCH-REPORTUS2011011486
INTERNATIONAL-SEARCH-REPORTUS6544424
INTERNATIONAL-SEARCH-REPORTWO2014051503

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Abhinav A. Shukla, Jagannadha Rao Kandula, "Chapter 3 - Harvest and recovery of monoclonal antibodies: Cell removal and clarification", Abhinav A. Shukla, Jagannadha Rao Kandula, Uwe Gottschalk, Process Scale Purification of Antibodies, (20090101), pages 53 - 78, XP055927488-
OPPOSITION- Anonymous, "ReadyToProcess™ - hollow fiber cartridges", (20210429), pages 1 - 6, Cytiva, URL: https://cdn.cytivalifesciences.com/api/public/content/digi-23574-pdf, (20231212), XP093111277-
OPPOSITION- Asakura Tomoko, Kiyoshi Toda, "Ethanol production by high cell-density culture with periodic reversion of circulating flow in cross-flow filtration (English Translation enclosed)", Hakkokogaku, (19910101), vol. 69, no. 4, pages 225 - 232, XP055927426-
OPPOSITION- "Chapters 6 and 11", Ozturk et al., CELL CULTURE TECHNOLOGY FOR PHARMACEUTICAL AND CELL-BASED THERAPIES, (20060101), pages 155 - 224, 387 - 416, ISBN 978-0-8247-5334-4, XP055680459-
OPPOSITION- Manohar Kalyanpur, "Membrane Separations", Manohar Kalyanpur, Flickinger et al., Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis and Bioseparation, (19990101), pages 1695 - 1705, ISBN 978-0-471-13822-8, XP055680453-
OPPOSITION- Mohamed El-Rubeai, Cell Engineering, Vol 7: Antibody Expression and Production, (20110101), pages 34 - 39, XP055927499-
OPPOSITION- SPECTRUM LABORATORIES, INC., "Conversion of Bioreactors to Continuous Perfusion Using Hollow Fiber Cell Separators", Practical aspects, (19890000), pages FP, 1 - 29, XP055155533-
OPPOSITION- "Watson-Marlow 620UN / 620U, 620SN / 620S pumps", User Manual, pages 1 - 100-
OPPOSITION- CLINCKE et al., "Very High Density of Chinese Hamster Ovary Cells in Perfusion by Alternating Tangential Flow or Tangential Flow Filtration in WAVE", Biotechnol. Prog., (20130000), vol. 29, doi:10.1002/btpr.1703, pages 768 - 777, XP055168922
OPPOSITION- CLINCKE et al., "Very High Density of CHO Cells in Perfusion by ATF or TFF in WAVE Bioreactor?. Part I. Effect of the Cell Density on the Process", Biotechnol. Prog., (20130000), vol. 29, doi:10.1002/btpr.1704, pages 754 - 767, XP055532937
OPPOSITION- CASTILHO et al., "Cell retention devices for suspended- cell perfusion cultures", Adv Biochem Engin Biotechnol, (20020000), vol. 74, doi:10.1007/3-540-45736-4_7, pages 129 - 169, XP009038515
OPPOSITION- Smith et al., "Experience in scale-up of homogeneous perfusion culture for hybridomas", BIOPROCESS ENGINEERING, Berlin/Heidelberg , (19910101), vol. 6, no. 5, doi:10.1007/BF00369714, ISSN 0178-515X, pages 213 - 219, XP055927577
OPPOSITION- Groot et al., "Process engineering for a membrane recycle fermentor", BIOPROCESS ENGINEERING, Berlin/Heidelberg , (19930101), vol. 8, no. 5-6, doi:10.1007/BF00369835, ISSN 0178-515X, pages 235 - 246, XP055927609
OPPOSITION- BELFORT et al., "The behavior of suspensions and macromolecular solutions in crossflow microfiltration", Journal of Membrane Science, NL , (19941128), vol. 96, no. 01/02, doi:10.1016/0376-7388(94)00119-7, ISSN 0376-7388, pages 1 - 58, XP000488256
OPPOSITION- CLINCKE et al., "Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor?", BMC Proceedings, (20110000), vol. 5, doi:10.1186/1753-6561-5-S8-P105, page P105, XP021114355

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents